Literature DB >> 11641058

Expressions of beta-defensins in human keratinocyte cell lines.

S J Seo1, S W Ahn, C K Hong, B I Ro.   

Abstract

BACKGROUND: Defensins, a major family of antimicrobial peptides, are small cationic, cysteine-rich peptides with a wide range of antimicrobial activity. In human, beta-defensin-1 was isolated from urine and cervical mucous suggesting that this peptide plays an antimicrobial role in the genitourinary tract. Beta-defensin-2 was identified in psoriatic scale produced by keratinocytes suggesting that this peptide contributes to defend the expansive surface of the integuments.
OBJECTIVE: Current research was done to investigate the expression and modulation of beta-defensin mRNA in human keratinocyte cell lines.
METHODS: HaCaT and A431 cell lines were used to all culture experiments. Cultured human keratinocytes were stimulated with ultraviolet (UV) B irradiation or tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) to determine whether defensin mRNA production occurred. Reverse transcription-polymerase chain reaction (RT-PCR) was performed to amplify defesin cDNA from stimulated keratinocytes, and southern blots were used to verify the specificity of RT-PCR amplication products.
RESULTS: Expression of human beta-defensins was upregulated with UVB irradiation, TNF-alpha and LPS in HaCaT cells and in comparison to the control, significantly higher at 6 h post stimulation with UVB 100 mJ/cm2 and peak at 12 to 18 h post stimulation with UVB 30 mJ/cm2, TNF-alpha and LPS. A431 cells did not show expression of human beta-defensins in unstimulated state, even after irradiation with UVB or TNF-alpha or LPS.
CONCLUSIONS: This report demonstrates the presence of defensin in human keratinocytes and capacity of human keratinocytes to produce defensin mRNA in response to UVB irradiation, TNF-alpha and LPS. Release of defensins by keratinocytes in response to cytokines elaborated in inflammation may contribute to the host defense responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641058     DOI: 10.1016/s0923-1811(01)00135-9

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  6 in total

1.  Antialarmin effect of tick saliva during the transmission of Lyme disease.

Authors:  Claire Marchal; Frederic Schramm; Aurélie Kern; Benjamin J Luft; Xiaohua Yang; Tim J Schuijt; Tim Schuijt; Joppe W Hovius; Joppe Hovius; Benoît Jaulhac; Nathalie Boulanger
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

2.  Non-coding Double-stranded RNA and Antimicrobial Peptide LL-37 Induce Growth Factor Expression from Keratinocytes and Endothelial Cells.

Authors:  Christopher A Adase; Andrew W Borkowski; Ling-Juan Zhang; Michael R Williams; Emi Sato; James A Sanford; Richard L Gallo
Journal:  J Biol Chem       Date:  2016-04-05       Impact factor: 5.157

Review 3.  β-Defensins in the Fight against Helicobacter pylori.

Authors:  Raffaela Pero; Lorena Coretti; Ersilia Nigro; Francesca Lembo; Sonia Laneri; Barbara Lombardo; Aurora Daniele; Olga Scudiero
Journal:  Molecules       Date:  2017-03-07       Impact factor: 4.411

4.  Cutaneous antimicrobial peptides: New "actors" in pollution related inflammatory conditions.

Authors:  Brittany Woodby; Erika Pambianchi; Francesca Ferrara; Jean-Philippe Therrien; Alessandra Pecorelli; Nicolo' Messano; Mary Ann Lila; Giuseppe Valacchi
Journal:  Redox Biol       Date:  2021-03-31       Impact factor: 11.799

5.  Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases.

Authors:  Ji Eun Kim; Beom Joon Kim; Mi Sook Jeong; Seong Jun Seo; Myeung Nam Kim; Chang Kwun Hong; Byung In Ro
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

6.  Adiponectin Suppresses UVB-Induced Premature Senescence and hBD2 Overexpression in Human Keratinocytes.

Authors:  MinJeong Kim; Kui Young Park; Mi-Kyung Lee; Taewon Jin; Seong Jun Seo
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.